BioMérieux S.A.
BIM
Rangering i aksjer
#1762
bioMérieux S.A. is a global entity operating across the Americas, Europe, the... bioMérieux S.A. is a global entity operating across the Americas, Europe, the Middle East, Africa, and the Asia Pacific, specializing in the development and production of in vitro diagnostic solutions. The company's sophisticated systems utilize biological samples to identify infectious diseases, cardiovascular conditions, and various forms of cancer. Additionally, bioMérieux provides essential microbiological testing services for the manufacturing sectors, primarily serving the food, pharmaceutical, cosmetics, and veterinary industries. Its client base includes clinical and hospital laboratories, medical practitioners, blood banks, and industrial quality control facilities. Founded in 1963, originally under the name B-D Mérieux, bioMérieux S.A. maintains its headquarters in Marcy l'Etoile, France, and functions as a subsidiary of Institut Mérieux SA.
Aksjekurs
$103.91
Sist synkronisert: 2026-10-20
Markedsverdi
$12.23B
Endring (1 dag)
0.86%
Endring (1 år)
-18.64%
Land
FR
Handel BioMérieux S.A. (BIM)
Kategori
Healthcare
Antall utestående aksjer for BioMérieux S.A. (BIM)
Antall utestående aksjer per June 2026: 117.76M
Ifølge BioMérieux S.A. sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 117.76M. Ved slutten av December 2023 hadde selskapet 118.05M utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for BioMérieux S.A. (BIM) fra 2005 til 2026
Utestående aksjer ved utgangen av hvert år
| År | Utestående aksjer | Endre |
|---|---|---|
| 2026 (TTM) | 117.76M | 0.00% |
| 2024 | 117.77M | -0.24% |
| 2023 | 118.05M | 0.09% |
| 2022 | 117.95M | -0.27% |
| 2021 | 118.27M | 0.10% |
| 2020 | 118.15M | -0.13% |
| 2019 | 118.30M | 0.43% |
| 2018 | 117.79M | -0.07% |
| 2017 | 117.87M | -0.14% |
| 2016 | 118.04M | -0.30% |
| 2015 | 118.39M | 0.05% |
| 2014 | 118.33M | -0.13% |
| 2013 | 118.48M | 0.20% |
| 2012 | 118.24M | -0.10% |
| 2011 | 118.35M | -0.01% |
| 2010 | 118.36M | 0.00% |
| 2009 | 118.36M | 0.00% |
| 2008 | 118.36M | 0.00% |
| 2007 | 118.36M | 0.00% |
| 2006 | 118.36M | 0.00% |
| 2005 | 118.36M | 0.00% |
Utestående aksjer for lignende selskaper eller konkurrenter
| Selskap | Utestående aksjer | Forskjell | Land |
|---|---|---|---|
| 371.00M | 215.05% |
US
|
|
| 705.30M | 498.93% |
US
|
|
| 143.28M | 21.67% |
US
|
|
| - | - |
CN
|
|
| 282.00M | 139.47% |
US
|
